Epileptic seizures in patients with COVID-19: A systematic review of early evidences

Background: Global emergence of SARS-CoV-2 surfaced neurological complications amongst the patients. COVID-19 resembles with other coronavirus strains follows a trend complication, damage and encephalopathy, which entails considerable risks, requires attention for neurologists. This is, to our knowledge, first systematic review literature investigate solely elucidate seizure spectrum by unfolding epileptogenicity SARS CoV-2 potential pathways neuroinvasion.
 Methods: A search was performed in PubMed Embase database following standard guidelines, using specific keywords based on epileptic onset described from December 01, 2019, July 17, 2020
 Results: total 17 studies were included ranging case reports, series cases, multicentre cross-sectional study first-time associated an origin. We excavated causes complex related manifestations, e.g., cerebrovascular diseases, encephalitis, demyelinating lesions, cytokine storm proposed routes entry into nervous system understand mechanism seizure.
 Conclusion: is potent neuropathogen new seizures should get diagnostic recognition evade possible deterioration conditions. However, more shreds evidence future will further epileptogenic pandemic.